Activas Generics
Allergan Aesthetics launches Skin Quality Index for aesthetic consultations
Spanning four dimensions of skin health, the framework introduces 15 terms and definitions
Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions
New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...
FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar
Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease
Sandoz separates from Novartis as an independent spin-off company
The split allows Sandoz to strengthen its position in generics and biosimilars
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Nearly 500,000 died from an opioid overdose between 1999 and 2019
Sandoz launches generic oncology treatment in Europe
Lenalidomide can be used to treat patients with haemato-onocology conditions, following recommendations from recent European Society for Medical Oncology (ESMO) guidelines
Teva reaches $925,000 settlement to resolve drug price-fixing claims
Last year, the US Department of Justice charged Teva for conspiring with competitors in a generic drug price-fixing probe
Pfizer, Sanofi and others set to increase US drug prices in 2021
Pressure from COVID-19 restrictions leads to drug price increases
US charges Teva for generic drug price-fixing plot
Company maintains it has not committed any wrongdoing
FDA approves Allergan’s biodegradable glaucoma implant drug
Reduces intraocular pressure in glaucoma or ocular hypertension
Allergan and Editas claim a CRISPR first in inherited blindness study
Partners are first to use CRISPR to edit cells inside the body
